Journal article
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel.
- Abstract:
-
The current standard therapy for patients with diabetic macular oedema (DME)--focal/grid laser photocoagulation--usually does not improve impaired vision, and many patients lose vision despite laser therapy. Recent approval of ranibizumab by the European Medicines Agency to treat visual impairment due to DME fulfils the previously unmet medical need for a treatment that can improve visual acuity (VA) in these patients. We reviewed 1- and 2-year clinical trial findings for ranibizumab used as ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Eye (London, England)
- Volume:
- 26
- Issue:
- 4
- Pages:
- 485-493
- Publication date:
- 2012-04-01
- DOI:
- EISSN:
-
1476-5454
- ISSN:
-
0950-222X
- Source identifiers:
-
325823
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:325823
- UUID:
-
uuid:3d223b8b-6726-4393-9633-c20cc3399fcc
- Local pid:
- pubs:325823
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record